PATENT CLAIM ANALYSIS

Application Number: 16277689
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "045000"]

Abstract:
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.

Claim (Index 29):
The method of  claim 28 , wherein the cromolyn sodium in the pharmaceutical composition is present at a concentration of from about 2% by weight to about 6% weight.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.26829
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15887830', '15750811', '15750809', '14686535', '16273987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8018442187533839
- 35 USC 102 Novelty (BERT): 0.6392121064282715
- Combined Prediction Score: 0.7855810075208727
- Mean Citation Score: 431.317602
- Max Citation Score: 721.60675
- Similarity Product: 529.9203225417137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test